Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C J Ertl

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Revue Scientifique Et Technique (International Office of Epizootics)|February 13, 2019
Human immune responses to traditional and novel rabies vaccinesH C J Ertl
Current Gene Therapy|April 28, 2005
Adenoviral gene delivery for HIV-1 vaccinationT Vanniasinkam, H C J Ertl
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responsesA Reyes-Sandoval, H C J Ertl
Virology|October 18, 2005
DNA immunization using a non-viral promoterT Vanniasinkam, S T Reddy, H C J Ertl
Scandinavian Journal of Immunology|September 18, 2002
An experimental vaccine expressing wild-type p53 induces protective immunity against glioblastoma cells with high levels of endogenous p53M Blaszczyk-Thurin, I O Ertl, H C J Ertl
Cellular Immunology|November 12, 2003
Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virusA R Pinto, A Reyes-Sandoval, H C J Ertl
Virology|February 8, 2003
T helper cell-independent antibody responses to the transgene product of an e1-deleted adenoviral vaccine require NK1.1 T cellsZ Q Xiang, G P Gao, Y Li, et al.
Vaccine|January 27, 2004
Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vectorA R Pinto, J C Fitzgerald, G P Gao, et al.
Gene Therapy|April 4, 2015
Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challengeH Zhang, X Tang, C Zhu, et al.
Journal of Virology|September 27, 2003
Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrierZ Q Xiang, G P Gao, A Reyes-Sandoval, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Revue Scientifique Et Technique (International Office of Epizootics)|February 13, 2019
Human immune responses to traditional and novel rabies vaccinesH C J Ertl
Current Gene Therapy|April 28, 2005
Adenoviral gene delivery for HIV-1 vaccinationT Vanniasinkam, H C J Ertl
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responsesA Reyes-Sandoval, H C J Ertl
Virology|October 18, 2005
DNA immunization using a non-viral promoterT Vanniasinkam, S T Reddy, H C J Ertl
Scandinavian Journal of Immunology|September 18, 2002
An experimental vaccine expressing wild-type p53 induces protective immunity against glioblastoma cells with high levels of endogenous p53M Blaszczyk-Thurin, I O Ertl, H C J Ertl
Cellular Immunology|November 12, 2003
Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virusA R Pinto, A Reyes-Sandoval, H C J Ertl
Virology|February 8, 2003
T helper cell-independent antibody responses to the transgene product of an e1-deleted adenoviral vaccine require NK1.1 T cellsZ Q Xiang, G P Gao, Y Li, et al.
Vaccine|January 27, 2004
Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vectorA R Pinto, J C Fitzgerald, G P Gao, et al.
Gene Therapy|April 4, 2015
Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challengeH Zhang, X Tang, C Zhu, et al.
Journal of Virology|September 27, 2003
Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrierZ Q Xiang, G P Gao, A Reyes-Sandoval, et al.
Pageof 2